NASDAQ
No price data available for this timeframe.
Arcturus Therapeutics Holdings Inc. (ARCT) has a price/sales ratio of 2.50x as of Friday, May 22, 2026. This represents a 88.85% decrease compared to its 12-month average of 22.41x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.